Obesity

Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study

Eur J EndocrinolPublished Cohort study

Authors' conclusion

Overweight occurs in almost half of long-term survivors. There was no overall increased incidence of overweight compared to controls. We identified factors associated with overweight, as well as subgroups of survivors in whom DXA can more reliably assess overweight.

Study context

Population
Adult long-term survivors of childhood cancer treated 1963–2002, DCCSS-LATER cohort; mean age 35.5 years, follow-up 28.3 years
Participants
2,338 survivors
Exposure
Childhood cancer survivors vs LifeLines controls
Outcome
Prevalence of overweight and obesity, primarily defined by BMI
Methodological detailsnationwide, LifeLines cohort as reference
  • Nationwide
  • LifeLines cohort as reference

Main finding

As reported in the abstract

Overweight prevalence (BMI)
OutcomeMenWomen
Overweight prevalence (BMI)46.3%44.3%
Obesity11.2%15.9%
Morbid obesity2.4%5.4%

Observational data: associations, not effects.

Further findings

Risk factors associated with overweight

aOR (95% CI)
Overweight at cancer diagnosis3.83 (2.19–6.69)
Cranial radiotherapy3.21 (1.99–5.18)
GHDSeparate model1.61 (1.00–2.59)

Alternative overweight metrics

Low high-molecular-weight (HMW) adiponectin present in survivors (insensitive overweight marker)
4.5%
Additional overweight identified by DXA fat%-based classification, particularly after abdominal radiotherapy, total body irradiation, anthracyclines and platinum
30%
Overweight prevalence similar using body mass index (BMI), waist circumference (WC), waist/hip ratio (WHR) and waist/height ratio (WHtR)

Original publication

Prevalence, risk factors, and optimal way to determine overweight, obesity, and morbid obesity in the first Dutch cohort of 2338 long-term survivors of childhood cancer: a DCCSS-LATER study. Eur J Endocrinol. Published 14 October 2023. doi:10.1093/ejendo/lvad139

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.